Electromed, Inc. (ELMD)

28.00 +0.39 (+1.41%) USD  |  NYAM  |  Sep 04, 16:00
28.05 +0.05 (+0.18%) After-Hours: 20:00
More

Electromed Research and Development Expense (Quarterly) : 0.328M for June 30, 2026

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for ELMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 0.328M
March 31, 2026 0.361M
December 31, 2025 0.384M
September 30, 2025 0.241M
June 30, 2025 0.302M
March 31, 2025 0.277M
December 31, 2024 0.251M
September 30, 2024 0.166M
June 30, 2024 0.176M
March 31, 2024 0.167M
December 31, 2023 0.107M
September 30, 2023 0.206M
June 30, 2023 0.298M
March 31, 2023 0.166M
December 31, 2022 0.154M
September 30, 2022 0.298M
June 30, 2022 0.315M
March 31, 2022 0.336M
December 31, 2021 0.329M
September 30, 2021 0.376M
June 30, 2021 0.326M
March 31, 2021 0.4072M
December 31, 2020 0.5075M
September 30, 2020 0.4811M
June 30, 2020 0.4152M
Date Value
March 31, 2020 0.392M
December 31, 2019 0.1435M
September 30, 2019 0.0989M
June 30, 2019 0.1065M
March 31, 2019 0.1708M
December 31, 2018 0.2378M
September 30, 2018 0.0682M
June 30, 2018 0.0406M
March 31, 2018 0.0427M
December 31, 2017 0.0568M
September 30, 2017 0.0707M
June 30, 2017 0.0646M
March 31, 2017 0.0806M
December 31, 2016 0.1008M
September 30, 2016 0.3508M
June 30, 2016 0.1973M
March 31, 2016 0.0844M
December 31, 2015 0.0571M
September 30, 2015 0.0415M
June 30, 2015 0.0784M
March 31, 2015 0.0783M
December 31, 2014 0.0836M
September 30, 2014 0.0753M
June 30, 2014 0.0611M
March 31, 2014 0.1032M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Senseonics Holdings, Inc. 11.64M
Envoy Medical, Inc. 3.132M
Accuray, Inc. 7.707M
Micron Solutions, Inc. --
Orthofix Medical, Inc. 14.86M